ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20%

February 2, 1990

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008

Program Announcements, RFA In Radiation Effects Available

September 24, 1982

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007